Loading…
Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus
Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes...
Saved in:
Published in: | Cancer management and research 2022-01, Vol.14, p.3493-3505 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743 |
---|---|
cites | cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743 |
container_end_page | 3505 |
container_issue | |
container_start_page | 3493 |
container_title | Cancer management and research |
container_volume | 14 |
creator | Zheng, Danni Yang, Jiawen Qian, Jiali Jin, Lingli Huang, Guanli |
description | Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM.
Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated.
The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654.
In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM. |
doi_str_mv | 10.2147/CMAR.S366270 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A732979964</galeid><doaj_id>oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59</doaj_id><sourcerecordid>A732979964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</originalsourceid><addsrcrecordid>eNptks9v0zAUgCMEYmNw44wsceFAiu0kdnxBqgqDSV2ZRjlbjv3SukrjYDtM_VP4b3FpGStCtuRf3_tsP70se0nwhJKSv5tdT28nXwvGKMePsnNCuMhJQenjB_Oz7FkIG4yZIEX5NDsrWMULwvh59vPSNt72bgV9Hl2-gDF6N6xth25VtA6pgBRawB268WCsjs4j16IZ9NGrDs1322GNFs4AuoaoQuo2INujmxScmIDubFyn1WC7TvkdWq533lmDZqrX4JHqDVruBkAUfbCqgQghibrOxjE8z560qgvw4jheZN8uPy5nn_P5l09Xs-k811Vdx5ybEkrcckOgNBUYzAXQBtdcQVlj0MCpMJwmAtPKADetINhUijLFVMHL4iK7OniNUxs5eLtND5VOWfl7w_mVVD5a3YFkyaKgYUzXdak1bnjJqcJaF5VgphLJ9f7gGsZmC0Yf0nQiPT3p7Vqu3A8peC04Jknw5ijw7vsIIcqtDTplRPXgxiApr-qK10SwhL7-B9240fcpVYlijFSC0_IvtVLpA7ZvXbpX76VyygsquBBsT03-Q6VmYGu166G1af8k4O0hQHsXgof2_o8Ey31Zyn1ZymNZJvzVw7zcw3_qsPgF4Z7dvg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2766159724</pqid></control><display><type>article</type><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><source>Publicly Available Content Database</source><source>Taylor & Francis Open Access Journals</source><source>PubMed Central</source><creator>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</creator><creatorcontrib>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</creatorcontrib><description>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM.
Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated.
The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654.
In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</description><identifier>ISSN: 1179-1322</identifier><identifier>EISSN: 1179-1322</identifier><identifier>DOI: 10.2147/CMAR.S366270</identifier><identifier>PMID: 36573167</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Calibration ; Cancer patients ; Care and treatment ; clnm ; Complications and side effects ; Datasets ; Diabetes ; Fibrin ; Fibrinogen ; fnr ; Lymphatic system ; Lymphocytes ; Medical colleges ; Medical prognosis ; Medical research ; Medicine, Experimental ; Metastasis ; Multivariate analysis ; Neutrophils ; nomogram ; Nomograms ; Original Research ; Patients ; Performance evaluation ; predictor ; Prognosis ; ptc ; Regression analysis ; Risk factors ; Surgery ; Surgical outcomes ; Thyroid cancer ; Thyroxine ; Type 2 diabetes</subject><ispartof>Cancer management and research, 2022-01, Vol.14, p.3493-3505</ispartof><rights>2022 Zheng et al.</rights><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Zheng et al. 2022 Zheng et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</citedby><cites>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2766159724/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2766159724?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36573167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Danni</creatorcontrib><creatorcontrib>Yang, Jiawen</creatorcontrib><creatorcontrib>Qian, Jiali</creatorcontrib><creatorcontrib>Jin, Lingli</creatorcontrib><creatorcontrib>Huang, Guanli</creatorcontrib><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><title>Cancer management and research</title><addtitle>Cancer Manag Res</addtitle><description>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM.
Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated.
The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654.
In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</description><subject>Calibration</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>clnm</subject><subject>Complications and side effects</subject><subject>Datasets</subject><subject>Diabetes</subject><subject>Fibrin</subject><subject>Fibrinogen</subject><subject>fnr</subject><subject>Lymphatic system</subject><subject>Lymphocytes</subject><subject>Medical colleges</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metastasis</subject><subject>Multivariate analysis</subject><subject>Neutrophils</subject><subject>nomogram</subject><subject>Nomograms</subject><subject>Original Research</subject><subject>Patients</subject><subject>Performance evaluation</subject><subject>predictor</subject><subject>Prognosis</subject><subject>ptc</subject><subject>Regression analysis</subject><subject>Risk factors</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Thyroid cancer</subject><subject>Thyroxine</subject><subject>Type 2 diabetes</subject><issn>1179-1322</issn><issn>1179-1322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks9v0zAUgCMEYmNw44wsceFAiu0kdnxBqgqDSV2ZRjlbjv3SukrjYDtM_VP4b3FpGStCtuRf3_tsP70se0nwhJKSv5tdT28nXwvGKMePsnNCuMhJQenjB_Oz7FkIG4yZIEX5NDsrWMULwvh59vPSNt72bgV9Hl2-gDF6N6xth25VtA6pgBRawB268WCsjs4j16IZ9NGrDs1322GNFs4AuoaoQuo2INujmxScmIDubFyn1WC7TvkdWq533lmDZqrX4JHqDVruBkAUfbCqgQghibrOxjE8z560qgvw4jheZN8uPy5nn_P5l09Xs-k811Vdx5ybEkrcckOgNBUYzAXQBtdcQVlj0MCpMJwmAtPKADetINhUijLFVMHL4iK7OniNUxs5eLtND5VOWfl7w_mVVD5a3YFkyaKgYUzXdak1bnjJqcJaF5VgphLJ9f7gGsZmC0Yf0nQiPT3p7Vqu3A8peC04Jknw5ijw7vsIIcqtDTplRPXgxiApr-qK10SwhL7-B9240fcpVYlijFSC0_IvtVLpA7ZvXbpX76VyygsquBBsT03-Q6VmYGu166G1af8k4O0hQHsXgof2_o8Ey31Zyn1ZymNZJvzVw7zcw3_qsPgF4Z7dvg</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Zheng, Danni</creator><creator>Yang, Jiawen</creator><creator>Qian, Jiali</creator><creator>Jin, Lingli</creator><creator>Huang, Guanli</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><author>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Calibration</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>clnm</topic><topic>Complications and side effects</topic><topic>Datasets</topic><topic>Diabetes</topic><topic>Fibrin</topic><topic>Fibrinogen</topic><topic>fnr</topic><topic>Lymphatic system</topic><topic>Lymphocytes</topic><topic>Medical colleges</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metastasis</topic><topic>Multivariate analysis</topic><topic>Neutrophils</topic><topic>nomogram</topic><topic>Nomograms</topic><topic>Original Research</topic><topic>Patients</topic><topic>Performance evaluation</topic><topic>predictor</topic><topic>Prognosis</topic><topic>ptc</topic><topic>Regression analysis</topic><topic>Risk factors</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Thyroid cancer</topic><topic>Thyroxine</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Danni</creatorcontrib><creatorcontrib>Yang, Jiawen</creatorcontrib><creatorcontrib>Qian, Jiali</creatorcontrib><creatorcontrib>Jin, Lingli</creatorcontrib><creatorcontrib>Huang, Guanli</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer management and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Danni</au><au>Yang, Jiawen</au><au>Qian, Jiali</au><au>Jin, Lingli</au><au>Huang, Guanli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</atitle><jtitle>Cancer management and research</jtitle><addtitle>Cancer Manag Res</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>14</volume><spage>3493</spage><epage>3505</epage><pages>3493-3505</pages><issn>1179-1322</issn><eissn>1179-1322</eissn><abstract>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM.
Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated.
The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654.
In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>36573167</pmid><doi>10.2147/CMAR.S366270</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1179-1322 |
ispartof | Cancer management and research, 2022-01, Vol.14, p.3493-3505 |
issn | 1179-1322 1179-1322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59 |
source | Publicly Available Content Database; Taylor & Francis Open Access Journals; PubMed Central |
subjects | Calibration Cancer patients Care and treatment clnm Complications and side effects Datasets Diabetes Fibrin Fibrinogen fnr Lymphatic system Lymphocytes Medical colleges Medical prognosis Medical research Medicine, Experimental Metastasis Multivariate analysis Neutrophils nomogram Nomograms Original Research Patients Performance evaluation predictor Prognosis ptc Regression analysis Risk factors Surgery Surgical outcomes Thyroid cancer Thyroxine Type 2 diabetes |
title | Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibrinogen-to-Neutrophil%20Ratio%20as%20a%20New%20Predictor%20of%20Central%20Lymph%20Node%20Metastasis%20in%20Patients%20with%20Papillary%20Thyroid%20Cancer%20and%20Type%202%20Diabetes%20Mellitus&rft.jtitle=Cancer%20management%20and%20research&rft.au=Zheng,%20Danni&rft.date=2022-01-01&rft.volume=14&rft.spage=3493&rft.epage=3505&rft.pages=3493-3505&rft.issn=1179-1322&rft.eissn=1179-1322&rft_id=info:doi/10.2147/CMAR.S366270&rft_dat=%3Cgale_doaj_%3EA732979964%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2766159724&rft_id=info:pmid/36573167&rft_galeid=A732979964&rfr_iscdi=true |